Ziopharm Oncology (ZIOP) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Ziopharm Oncology Reports Second Quarter 2020 Financial Results and Provides Corporate Update
August 6, 2020 4:04 PM EDTEnrollment completed in Controlled IL-12 phase 2 clinical trial with Regenerons Libtayo® First patient with DIPG dosed in phase 1/2 pediatric brain tumor trial of Contolled IL-12 Work restrictions at the NCI and MD Anderson easing; MD Anderson initiated phase 1 CD19-specific CAR-T clinical trial using RPM Eden BioCell on track for Taiwan IND filing for autologus CAR-T clinical trial this year
Company to host conference call and webcast today, August 6, at 4:30 p.m. EDT
BOSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) --... More
